AndrewHantelMD

Hematologic Oncology

Assistant Professor of Medicine, Dana-Farber Cancer Institute, Harvard Medical School Center for Bioethics, Harvard Medical School

Dr. Hantel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Harvard Medical SchoolPost-Doctoral Fellowship, 2019 - 2021
University of ChicagoFellowship, Hematology and Medical Oncology, 2016 - 2019
University of Chicago Medical CenterFellowship, General Internal Medicine and Clinical Medical Ethics, 2015 - 2016
University of ChicagoResidency, Internal Medicine, 2013 - 2016
Loyola University Chicago Stritch School of MedicineClass of 2013

PubMed

The Promise and Perils of Diversity Action Plans for Clinical Trials.
Tanvee Varma, Barbara E Bierer, Andrew Hantel
JAMA. 2024-12-03
The Duffy Null Phenotype - Addressing a Source of Discrimination in Cancer Care.
Andrew Hantel, Stephen P Hibbs, Lauren E Merz, Gregory A Abel
The New England Journal of Medicine. 2024-11-28
Clinical ethics consultation services: public-facing information on NCI-designated cancer center websites.
Erica Koranteng, Colin Cernik, Erin Gallagher, Andrew Hantel, Jonathan Marron
The Oncologist. 2024-10-03

Lectures

The practical ethics of medication shortages: Understanding patient preferences for allocation, decision making, and disclosure through narrative inquiry.
2019 ASCO Annual Meeting - 6/1/2019